| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2020 | TMO Thermo Fisher Scientific Inc. | Williamson Stephen68 | Sr. VP And CFO | Sell | 2,500 | $291.03 | $727,575.00 | -5.8% | |
| Feb 28, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 125,000 | $1.46 | $182,099.46 | - | |
| Feb 28, 2020 | EXAS Exact Sciences Corp | Doyle James Edward75 | Director | Sell | 2,000 | $77.54 | $155,080.00 | -5.8% | |
| Feb 28, 2020 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 9,750 | $80.17 | $781,657.50 | -1.0% | |
| Feb 28, 2020 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 2,383 | $80.17 | $191,045.11 | -3.9% | |
| Feb 27, 2020 | CRL Charles River Laboratories International, Inc. | Chubb Stephen D | Director | Sell | 2,464 | $160.89 | $396,437.40 | -5.9% | |
| Feb 27, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 250,000 | $1.48 | $369,816.26 | - | |
| Feb 27, 2020 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 13,875 | $80.27 | $1,113,746.25 | -1.4% | |
| Feb 27, 2020 | EXAS Exact Sciences Corp | Stenhouse Mark | President, Cologuard | Sell | 1,051 | $80.27 | $84,363.77 | -6.0% | |
| Feb 27, 2020 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 1,627 | $80.27 | $130,599.29 | -2.8% | |
| Feb 26, 2020 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 4,188 | $162.26 | $679,534.84 | -3.7% | |
| Feb 26, 2020 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 25,124 | $162.25 | $4,076,411.01 | -1.7% | |
| Feb 26, 2020 | WAT Waters Corp /de/ | Kim Francis | SVP Global Operations | Sell | 1,471 | $207.33 | $304,982.43 | -45.6% | |
| Feb 25, 2020 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 538 | $80.00 | $43,040.00 | -29.2% | |
| Feb 25, 2020 | PSNL Personalis, Inc. | Chen Richard70 | Chief Scientific Officer | Sell | 101,000 | $8.77 | $885,770.00 | -63.1% | |
| Feb 25, 2020 | A Agilent Technologies, Inc. | Gonsalves Rodney65 | V.p., Corporate Controller | Sell | 1,000 | $80.02 | $80,024.16 | -1.1% | |
| Feb 25, 2020 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 4,910 | $85.11 | $417,890.10 | -8.3% | |
| Feb 25, 2020 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 18,115 | $85.11 | $1,541,767.65 | -1.8% | |
| Feb 24, 2020 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 8,211 | $166.72 | $1,368,952.80 | -11.3% | |
| Feb 24, 2020 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 47,303 | $166.77 | $7,888,923.05 | -5.1% | |
| Feb 24, 2020 | TTOO T2 Biosystems, Inc. | Lowery Thomas J. | Chief Scientific Officer | Sell | 5,808 | $0.82 | $4,762.56 | -7.8% | |
| Feb 24, 2020 | TTOO T2 Biosystems, Inc. | Barclay Alec | SVP, Operations | Sell | 5,808 | $0.82 | $4,762.56 | -11.1% | |
| Feb 24, 2020 | TTOO T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Sell | 5,808 | $0.82 | $4,762.56 | -8.7% | |
| Feb 24, 2020 | TTOO T2 Biosystems, Inc. | Sprague John M | Chief Financial Officer | Sell | 4,166 | $0.82 | $3,416.12 | -15.8% | |
| Feb 21, 2020 | WAT Waters Corp /de/ | Aleman Keeley A | SVP General Counsel &Corp Sec | Sell | 151 | $216.78 | $32,733.85 | -15.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.